Dr. Brett Sharp, a triple board-certified psychiatrist with extensive experience treating adults, children and adolescents has opened a new practice at Achieve TMS, 41750 Rancho Las Palmas Suite C3 in Rancho Mirage where patients will be seen Mondays – Saturdays beginning January 28. Known for effectively treating patients facing medical, neurological or developmental challenges that…
Brainsway was 1 of 8 total companies chosen for the Opioid Use Disorder Challenge! Brainsway TMS is a leading machine officially cleared by the FDA in the United States. The Brainsway machine has been widely tested in more than 60 clinical trials around the world providing deeper transcranial magnetic stimulation. Brainsway machines are used in…
Post-traumatic stress can come from really any negative experience in life, but with veterans, this disorder that impacts millions is even greater. Now, a new form of treatment is making strides in the medical field. To learn more, read the full article here.
FDA-Cleared Deep TMS Will Treat Obsessive Compulsive Disorder at Centers in San Diego, Anchorage and Portland, OR Achieve TMS/TMS Center of Alaska, the nation’s most trusted and most experienced provider of deep TMS (transcranial magnetic simulation) for the treatment of depression is now offering TMS treatment for obsessive compulsive disorder at centers in California, Oregon…
Achieve TMS, nation’s most trusted deep TMS* provider for depression, hires world-renown TMS researcher Lindsay Oberman, Ph.D. as Senior Scientific Advisor Dr. Oberman to assist with research, training and education on Transcranial Magnetic Stimulation (TMS) for treatment of several neurological diseases San Diego, CA – Achieve TMS, the nation’s most trusted and most experienced…
Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD). “Transcranial magnetic stimulation has shown its potential to help patients suffering from depression and headaches,” said Carlos Peña, Ph.D., M.S., director of the Division of Neurological and Physical Medicine Devices in…
Harvard Medical School is talking about TMS and the positive impact it has on treating depression. According to them, “Approximately 50% to 60% of people with depression who have tried and failed to receive benefit from medications experience a clinically meaningful response with TMS.” To learn more about Harvard’s findings, check out their article…
This month, San Diego Woman the Magazine features our medical director, Dr. Shashita Inamdar, in its ‘Inspirational Women’ issue. This issue pays homage to women who have forged a path and overcome obstacles to accomplish things that they never dreamed to be possible. Dr. Inamdar, the medical director at Achieve TMS, is one of these…
Depression, or major depressive disorder, is a significant cause of disability worldwide. This devastating disease is very common. It affects 10% of individuals in the U.S. at any one time and one in six people during their lifetime. The good news is that depression is treatable. The majority of patients who receive treatment recover or experience…
Depression is as complex as it is devastating. This disease affects one out of every 6 people at some point in their lifetime. Incorporating both mental and physiological elements, there are many factors that can contribute to the development and recurrence of depression. Though it is still not fully understood, here is what we currently…
In today’s fast-paced and ever-evolving society, there are many factors that may have a negative effect on your mental health. These include hectic work schedules, a busy family life, natural disasters, and life-changing events, and ever increasing exposure to screen time, among others. The natural aging process also influences mental changes, such as decreased mental…
As of 2010, almost 17% of Americans were experiencing the debilitating symptoms of major depressive disorder – or MDD. The number of sufferers continues to soar, with the national statistics for 2016 indicating that up to 7% of the population struggles with an acute period of depression over the course of any given year. With…
Within California, Oregon, and Alaska, Transcranial Magnetic Stimulation has been approved for use with treatment resistant depression by several insurance providers. Insurances that we’re in network with include Cigna, Anthem Blue Cross, Magellan, Tricare, Blue Shield of CA, Blue Shield Federal Employee, Optum, Aetna, MHN, Healthnet, Beacon, Prime Health Services, Provider Select, Medicare, Providence Preferred, Providence Health Plan, Regence Blue Cross Blue Shield, First Choice Health Network, First Health National Network, Pacificsource, Moda, OHA (fee for service only), First Health, and Premera Blue Cross. Please call us for a full list of providers. We would be happy to help check with your insurance regarding pre-approval.
*Unfortunately, Medi-cal currently does not cover TMS treatment in California. Please contact your Medi-cal provider to inquire further.
